Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Parkinson disease and vitamin D: an interplay between genes and the environment?
DeLuca GC, Li G, Ramagopalan S.
Arch Neurol. 2011 Dec;68(12):1615-6. No abstract available.
Related citations
Neurodegeneration across stages of cognitive decline in Parkinson disease.
Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM.
Arch Neurol. 2011 Dec;68(12):1562-8.
Neuroregeneration in neurodegenerative disorders.
Enciu AM, Nicolescu MI, Manole CG, Mureşanu DF, Popescu LM, Popescu BO.
BMC Neurol. 2011 Jun 23;11:75. Review.
Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.
Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P.
Brain Res. 2012 Jan 13;1432:95-113. Epub 2011 Nov 19.
The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
Domenger D, Dea D, Theroux L, Moquin L, Gratton A, Poirier J.
Exp Neurol. 2012 Jan;233(1):513-22. Epub 2011 Dec 3.
YajL, prokaryotic homolog of parkinsonism-associated protein DJ-1, functions as a covalent chaperone for thiol proteome.
Le HT, Gautier V, Kthiri F, Malki A, Messaoudi N, Mihoub M, Landoulsi A, An YJ, Cha SS, Richarme G.
J Biol Chem. 2012 Feb 17;287(8):5861-70. Epub 2011 Dec 7.
Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL.
Ren H, Fu K, Wang D, Mu C, Wang G.
J Biol Chem. 2011 Oct 7;286(40):35308-17. Epub 2011 Aug 18.
Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.
Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R.
J Biol Chem. 2011 Oct 7;286(40):34690-9. Epub 2011 Aug 10.
Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J, Vincze O, Virók D, Simon D, Bozsó Z, Tõkési N, Horváth I, Hlavanda E, Kovács J, Magyar A, Szũcs M, Orosz F, Penke B, Ovádi J.
J Biol Chem. 2011 Sep 30;286(39):34088-100. Epub 2011 Aug 8.
Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.
Lamberto GR, Torres-Monserrat V, Bertoncini CW, Salvatella X, Zweckstetter M, Griesinger C, Fernández CO.
J Biol Chem. 2011 Sep 16;286(37):32036-44. Epub 2011 Jul 27.
Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease.
Knebel W, Rao N, Uchimura T, Mori A, Fisher J, Gastonguay MR, Chaikin P.
J Clin Pharmacol. 2011 Dec 12. [Epub ahead of print]
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
Di Biasio F, Vanacore N, Fasano A, Modugno N, Gandolfi B, Lena F, Grillea G, Pietracupa S, Caranci G, Ruggieri S.
J Neural Transm. 2012 May;119(5):597-604. Epub 2011 Dec 13.
Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait.
Wilcox RA, Cole MH, Wong D, Coyne T, Silburn P, Kerr G.
J Neurol Neurosurg Psychiatry. 2011 Nov;82(11):1256-9. Epub 2010 Oct 22.
Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention.
Olivieri S, Conti A, Iannaccone S, Cannistraci CV, Campanella A, Barbariga M, Codazzi F, Pelizzoni I, Magnani G, Pesca M, Franciotta D, Cappa SF, Alessio M.
J Neurosci. 2011 Dec 14;31(50):18568-77.
Impaired endogenously evoked automated reaching in Parkinson's disease.
Torres EB, Heilman KM, Poizner H.
J Neurosci. 2011 Dec 7;31(49):17848-63.
Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill.
Isaias IU, Moisello C, Marotta G, Schiavella M, Canesi M, Perfetti B, Cavallari P, Pezzoli G, Ghilardi MF.
J Neurosci. 2011 Oct 12;31(41):14458-62.
Feedback timing modulates brain systems for learning in humans.
Foerde K, Shohamy D.
J Neurosci. 2011 Sep 14;31(37):13157-67.
Movement disorders: towards new therapies in Parkinson's disease.
Antonini A.
Lancet Neurol. 2012 Jan;11(1):7-8. No abstract available.
Pathological roles of α-synuclein in neurological disorders.
Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L.
Lancet Neurol. 2011 Nov;10(11):1015-25. Review. Erratum in: Lancet Neurol. 2011 Dec;10(12):1041.
Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease.
van der Hoorn A, Hof AL, Leenders KL, de Jong BM.
Mov Disord. 2012 Apr;27(4):580-1. doi: 10.1002/mds.24011. Epub 2011 Dec 15. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on